We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Jul 2021
  • Code : CMI1899
  • Industry : Medical Devices
  • Pages : 208
  • Formats :

Artificial bone is a bone-like material created in laboratory that can be used in bone grafts to replace human bone that was lost due to severe fractures or bone and joint diseases. Artificial bones are made from using materials such as ceramics, composite, polymer, hydroxyapatite, and others. Artificial bones are mostly used for the surgeries of spinal fusion, dental therapies, craniomaxillofacial surgery, joint reconstruction, and trauma & extremities. Artificial bones are also used for bone fractures fixation. For instance, according to the Centers for Disease Control and Prevention, 2018, around 800,000 cases are recorded for head injuries or hip fractures every year in the U.S. and around 300,000 cases of hip fractures in people of age 65 and above are observed every year in the U.S.

Global Artificial Bone Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of business across all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID-19 pandemic. Moreover, coronavirus pandemic has negatively impacted the development, production, and supply of artificial bones market. The government and the regulatory bodies of various countries are focusing on implementing various guidelines and initiatives to decrease or control the spread of the COVID-19 among individuals across the globe. For instance, on April 30, 2020, the American Academy of Orthopedic Surgeons published clinical considerations for its members to tackle the COVID-19 pandemic situation. Following are the guidelines provided by the American Academy of Orthopedic Surgeons to navigate through the COVID-19 pandemic:

  • First Priority: Safety of patients is considered to be the top most priority
  • Second Priority: Safety of health care personnel and staff
  • The members of American Academy of Orthopedic Surgeons should adhere to Centers for Disease Control Prevention (CDC) and relevant federal, state, and local public health guidance

Thus, impact of the coronavirus (COVID-19) pandemic is expected to limit growth of the global artificial bone market during the forecast period.

Figure 1. Global Artificial Bone Market Share (%), By Material, 2021 and 2028

Artificial Bone  | Coherent Market Insights

The global artificial bone market is estimated to be valued at US$ 1,375.1 million in 2021 and is expected to exhibit a CAGR of 5.6% during the forecast period (2021-2028).

CMI table icon

Artificial Bone Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,375.1 Mn
Historical Data for: 2018 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 5.6% 2028 Value Projection: US$ 2,017.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Material: Ceramics, Composite, Polymer, Hydroxyapatite, Others
  • By Application: Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma and Extremities
  • By End User: Hospitals, Specialty Clinics, Research Organization
Companies covered:

Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation, NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM.

Growth Drivers:
  • High prevalence of osteoporosis and increasing number of fractures 
  • Increasing product approvals/launches by companies
Restraints & Challenges:
  • High cost of orthopedic surgeries
  • Low mechanical strength of artificial bones

Increasing acquisitions by key players and increasing number of product approvals from regulatory bodies are expected to drive growth of global artificial bone market

Major factors assisting the market growth during the forecast period include rising number of acquisitions by the key players in the market. For instance, in November 2020, Stryker Corporation acquired Wright Medical Group N.V, a global medical device company. The acquisition enhanced Stryker Corporation’s global market position in products for upper extremities (shoulder, elbow, wrist, and hand), lower extremities (foot and ankle), and biologics market segments, and also providing significant opportunities to advance innovation in medical products and reach more patients.

Furthermore, key market players are focused on gaining approvals from regulatory bodies, which is expected to drive growth of the global artificial bone market. For instance, in August 2020, SurGenTec, LLC announced that they received 510k clearance from the U.S. Food and Drug Administration (FDA) for its quadphasic synthetic bone graft, OsteoFlo NanoPutty. OsteoFlo features the nano-surface technology and does not require mixing, reconstituting or preparation before its use.

Global Artificial Bone Market – Restraints

Growth of the global artificial bone market is expected to be hampered over the forecast period, owing to low mechanical strength and less osteogenic properties of the artificial bone materials. For instance, according to the U.S. National Library of Medicine report June 2018, synthetic or artificial material (ceramics, composite, polymer) used in bone fractures and other surgeries have various disadvantages such as faster reabsorption rate, which leads to lower mechanical strength and low osteoinductive or osteogenic properties.

Global Artificial Bone Market- Major Region

North America is the major region in global artificial bone market, which is estimated to be valued at US$ 551.7 Mn in 2021 and is estimated to increase to US$ 813.6 Mn by 2028, exhibiting a CAGR of 5.7% during the forecast period. The growth is attributed to key players in the region focusing on inorganic strategies such as agreements, in order to strengthen their presence in the region. For instance, in May 2018, DePuy Synthes, a subsidiary of Johnson & Johnson, announced an exclusive agreement with the U.S. with Prosidyan to promote FIBERGRAFT Family of Products of DePuy Synthes, a line of synthetic bone graft materials, which are ultra-porous, designed for ease of use, and indicated for use in spine surgeries.

Figure 2. Global Artificial Bone Market Value (US$ Mn) & Y -o-Y Growth (%), 2017-2028

Artificial Bone  | Coherent Market Insights

Global Artificial Bone Market - Competitive Landscape

Key players operating in the global artificial bone market include Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation, NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM.

Artificial bone refers to bone-like material created in a laboratory that can be used in bone grafts, to replace human bone that was lost due to severe fractures, diseases, and others. Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and have no antigen-antibody reaction. These bone grafts act as a mineral reservoir which induces new bone formation. Bone substitutes can be either derived from biological products such as ceramics, composite, polymer, hydroxyapatite, and others.

Market Dynamics

The increasing number of product launches is expected to drive the global artificial bone market. For instance, in October 2016, Stryker has announced the launch of its handheld bone graft delivery system. The LITe BIO Delivery System is approved for use in spinal fusion surgeries to deliver autograft, allograft, and synthetic material. The LITe BIO Delivery System was approved by the U.S. Foods and Drugs Administration in July 2017 for to improve visualization, to work under fluoroscopy.

However, growth of the global artificial bone market is expected to be hampered over the forecast period, owing to high cost of spinal fusion surgeries and joint replacement/ reconstruction. For instance, according to the MedSurge, a pharmaceutical company report 2018,  the cost of the spine fusion surgeries in Indian hospitals ranged from around US$ 4,800 to US$ 7,800 and the cost of the scoliosis spine surgery in India ranged from US$ 10,500 to US$ 11,500 in year 2018.

Key features of the study:

  • This report provides in-depth analysis of the global artificial bone market size (US$ Mn), and compound annual growth rate (CAGR) for the forecast period: 2021-2028, considering 2020 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global artificial bone market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation., NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global artificial bones market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for artificial bones market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Artificial Bone Market, By Material:
    • Ceramics
    • Composite
      • Polymer
      • Hydroxyapatite
      • Others
  • Global Artificial Bone  Market, By Application:
    • Spinal Fusion
    • Dental
    • Craniomaxillofacial
    • Joint Reconstruction
    • Trauma and Extremities
  • Global Artificial Bone Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Research Organization
  •  Global Artificial Bone Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Material:
        • Ceramics
        • Composite
        • Polymer
        • Hydroxyapatite
        • Others
      • By Application:
        • Spinal Fusion
        • Dental
        • Craniomaxillofacial
        • Joint Reconstruction
        • Trauma and Extremities
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Research Organization
  • Company Profiles
    • Medtronic Plc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Johnson & Johnson
    • Baxter International Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • NuVasive, Inc. 
    • Allosource
    • Curasan, Inc.
    • Ziacom Medical SLU
    • Orthofix International N.V
    • Biomatlante
    • DSM

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global artificial bone market is expected to exhibit a CAGR of 5.6%, during the forecast period (2021-2028).
The market is estimated to be valued at US$ 1,375.1 million in 2021.
The prominent players in the market include Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation, NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM.
The market is expected to be valued at US$ 2,017.6 million in 2028.
North America is the major region, which is expected to account for largest share in the market.
High prevalence of osteoporosis and increasing product approvals/launches by companies are expected to drive growth of the market during the forecast period.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo